Breakthrough Psychedelic Drug Shows Promise in Treating Postpartum Depression - HealingMaps
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.| HealingMaps
Insurance is one of the most misunderstood aspects of running a ketamine clinic. And wrong assumptions can expose clinics to significant risk. The post 5 Biggest Ketamine Clinic Professional Insurance Misconceptions appeared first on HealingMaps.| HealingMaps
Bryan Johnson, who transforms his body into an anti-aging science experiment, is now considering ketamine therapy. The post “Don’t Die” Biohacker Bryan Johnson Considers Ketamine as Latest Anti-Aging Tool appeared first on HealingMaps.| HealingMaps
The DEA requested that federal health officials conduct a medical review of psilocybin - a watershed moment for psychedelic medicine. The post Historic Move Could Transform Psilocybin Access for Terminally Ill Patients appeared first on HealingMaps.| HealingMaps
Doctors predicted six months of inpatient rehabilitation, but Hall walked out in six weeks. His secret? Psychedelic mushrooms. The post Aspen Skier’s Remarkable Recovery: Could Psychedelics Transform Brain Injury Treatment? appeared first on HealingMaps.| HealingMaps
Reunion Neuroscience announced positive results from its RECONNECT Phase 2 clinical trial evaluating postpartum depression.| HealingMaps
We reviewed recent patient reports on public communities, with our internal messaging in early August 2025 to gauge out of pocket prices for ketamine therapy. Figures are self reported, vary by protocol, and reflect local market conditions rather than clinical guidance. Where possible, we include direct quotes from individuals in each region to provide more […] The post Ketamine Therapy Cost Roundup: August 2025 appeared first on HealingMaps.| HealingMaps
The psychedelic drugs market is poised for explosive growth, with projections going from $3.63 billion in 2024 to $10.11 billion by 2032. The post Psychedelic Therapy Market Surges Toward $10 Billion Future appeared first on HealingMaps.| HealingMaps
PharmaTher has secured FDA approval for its ketamine product KETARx, which is specifically for surgical pain management. The post PharmaTher Achieves Historic Ketamine FDA Approval After Third Attempt appeared first on HealingMaps.| HealingMaps
These revenue leaks often remain invisible until they accumulate into thousands of lost income each month. Let's help you fix them. The post 7 Hidden Revenue Leaks Killing Your Ketamine Practice’s Profitability appeared first on HealingMaps.| HealingMaps
A groundbreaking case study reveals that tiny amounts of LSD may offer new hope for dogs suffering from separation anxiety. The post Scientists Test LSD Microdoses on Anxious Dogs With Surprising Results appeared first on HealingMaps.| HealingMaps
More than 49,000 Americans died by suicide in 2022, representing a 3% jump over the previous year and the highest number in U.S. history.| HealingMaps
California Governor Gavin Newsom has said that his state is "all in" on expanding psychedelic therapy access.| HealingMaps
TMS Or Ketamine: Which Is More Effective? Breaking Down The Two Alternative Treatments| HealingMaps
In this Q&A, we sit down with Dr. Haviva Malina, MD, a physician whose career bridges the critical fields of emergency medicine and mental health.| HealingMaps
We are helping the ketamine practitioners solve increased overhead costs, complex insurance requirements, and supply chain issues.| HealingMaps
A single dose of psilocybin may offer lasting relief from depression in cancer patients according to a new study.| HealingMaps
We are launching the Healing Health Alliance -- the ketamine industry's first GPO -- which will save clinics up to 20% on medical supplies.| HealingMaps
The Australian government has announced that Spravato will be added to the Pharmaceutical Benefits Scheme starting July 1.| HealingMaps
Find Ketamine Clinics and other psychedelic therapy providers near you. We are changing the way we treat mental health.| HealingMaps
In the first study of its kind, nearly 600 individuals shared how psychedelics impact intimacy and sexual expression.| HealingMaps
The study concluded that microdosing LSD did not significantly improve ADHD symptoms compared to a placebo.| HealingMaps
This white paper outlines the current, challenges, and potential solutions for incorporating psychedelics into mainstream medical practice.| HealingMaps
"Therapy is the treadmill...Mushrooms is this cold bucket of water," that provided profound realizations about his childhood.| HealingMaps
The Department of Defense just gave the University of Texas a $4.9M grant to study MDMA to treat PTSD in veterans groups.| HealingMaps
WSJ reporter Katherine Bindley breaks down the continued mainstreaming of psychedelic drug use in Silicon Valley.| HealingMaps
In this study, low-dose ketamine led to significant improvements in mood and cognition within just a few hours of treatment.| HealingMaps
Introducing Ketamine Insights Weekly, a new newsletter created specifically for the ketamine clinic and therapy industry.| HealingMaps
Psilocybe cubensis mushrooms are the most popular, most well-known, and most accepted species of psilocybin-containing mushrooms anywhere.| HealingMaps
For all the factors that can affect the length of your psychedelic journey on magic mushrooms, from dose to setting, read on!| HealingMaps
Another state to add to the list? A task force in Minnesota has advocated for legalizing psychedelic mushrooms.| HealingMaps
Find local psychedelic therapy clinics and therapists in your area.| HealingMaps
Ketamine is FDA approved to treat mental health issues. Find local Ketamine clinics and therapists in your area.| HealingMaps
Reilly Capps is the editorial director of HealingMaps. He has written about drugs for Rooster Magazine, The Washington Post, The Telluride Daily Planet, LucidNews, 5280, Chacruna, The Third Wave, and the MAPS Bulletin. A licensed EMT, he used to answer 911 calls on the ambulance in Boulder, Colo., where he learned how drugs affect a community. Read all his work at Authory.| HealingMaps
There are quite a few clinical trials that have produced surprising psychedelic therapy statistics. Here are a few of our favorite stats.| HealingMaps
Interested in joining a psychedelic clinical trial? Fill out our Psychedelic Clinical Trial Pre-Screening Questionnaire.| HealingMaps
PRIVACY NOTICE Effective Date: 10/17/2023 This Privacy Notice explains how Healing Maps (“Healing Maps”, “we”, “us”, “our”) collects your personal information as you use healingmaps.com (the “Website”), how we use this personal information, with whom we share your personal information, and your choices in connection with this. This Privacy Notice does not govern any third-party […]| HealingMaps
[vc_section full_width=”stretch_row” full_height=”yes” content_placement=”middle” css=”.vc_custom_1715954735450{background-image: url(https://healingmaps.com/wp-content/uploads/2022/12/clinical-hero_bg-1.jpg?id=32641) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”hero-banner”][vc_row gap=”30″ equal_height=”yes” content_placement=”middle”][vc_column width=”3/5″][vc_cus...| HealingMaps
Looking for alternatives to MDMA therapy for PTSD? There are several therapies that have proven effective in managing PTSD symptoms.| HealingMaps
What Is Ketamine Therapy? Here’s What The Research Says| HealingMaps
[vc_section full_width=”stretch_row” full_height=”yes” content_placement=”middle” css=”.vc_custom_1671542281138{background-image: url(https://healingmaps.com/wp-content/uploads/2022/12/clinical-hero_bg-1.jpg?id=32641) !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}” el_class=”hero-banner”][vc_row gap=”30″ equal_height=”yes” content_placement=”middle”][vc_column width=”2/3″][vc_cus...| HealingMaps
Ever wondered how much you could earn by participating in a psychedelic clinical trial? Let's break down the potential earnings| HealingMaps
